Evaluation of bovine spongiform encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines - Scientific guideline

HumanScientific guidelines

Polish is available via eTranslation, the European Commission's machine translation service.

Translate to Polish | Important information about machine translation

Evaluation of bovine spongiform encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines.

Keywords: /

Current effective version

Public statement on the evaluation of bovine spongiform encephalopathies (BSE) - risk via the use of materials of bovine origin in or during the manufacture of vaccines

Adopted Reference Number: EMEA/CPMP/BWP/476/01 Legal effective date:

English (EN) (21.44 KB - PDF)

Opublikowane po raz pierwszy: Ostatnia aktualizacja:
Zobacz

Share this page